Clinical Evaluation of a Metagenomics-Based Assay for Pneumonia Management
Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for bot...
Saved in:
Published in | Frontiers in microbiology Vol. 12; p. 751073 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
16.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (
n
= 12 in ICO,
n
= 18 in ICH) and targeted treatment initiation (
n
= 7 in ICO,
n
= 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings. |
---|---|
AbstractList | Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation (n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings. Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation ( n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation ( n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings. Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation (n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings.Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation (n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings. |
Author | Xie, Mingzhou Chen, Rongchang Li, Shaoqiang Cheng, Linling Li, Zhengtu Li, Xiaolei Xu, Teng Zhong, Nanshan He, Fusheng Zhan, Yangqing Guan, Wei-jie Ye, Feng |
AuthorAffiliation | 3 Key Laboratory of Animal Gene Editing and Animal Cloning in Yunnan Province and College of Veterinary Medicine, Yunnan Agricultural University , Kunming , China 5 Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen Institute of Respiratory Diseases , Shenzhen , China 2 Vision Medicals Co., Ltd. , Guangzhou , China 4 Department of Thoracic Surgery, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China 1 State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease , Guangzhou , China |
AuthorAffiliation_xml | – name: 2 Vision Medicals Co., Ltd. , Guangzhou , China – name: 1 State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease , Guangzhou , China – name: 4 Department of Thoracic Surgery, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China – name: 3 Key Laboratory of Animal Gene Editing and Animal Cloning in Yunnan Province and College of Veterinary Medicine, Yunnan Agricultural University , Kunming , China – name: 5 Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen Institute of Respiratory Diseases , Shenzhen , China |
Author_xml | – sequence: 1 givenname: Yangqing surname: Zhan fullname: Zhan, Yangqing – sequence: 2 givenname: Teng surname: Xu fullname: Xu, Teng – sequence: 3 givenname: Fusheng surname: He fullname: He, Fusheng – sequence: 4 givenname: Wei-jie surname: Guan fullname: Guan, Wei-jie – sequence: 5 givenname: Zhengtu surname: Li fullname: Li, Zhengtu – sequence: 6 givenname: Shaoqiang surname: Li fullname: Li, Shaoqiang – sequence: 7 givenname: Mingzhou surname: Xie fullname: Xie, Mingzhou – sequence: 8 givenname: Xiaolei surname: Li fullname: Li, Xiaolei – sequence: 9 givenname: Rongchang surname: Chen fullname: Chen, Rongchang – sequence: 10 givenname: Linling surname: Cheng fullname: Cheng, Linling – sequence: 11 givenname: Nanshan surname: Zhong fullname: Zhong, Nanshan – sequence: 12 givenname: Feng surname: Ye fullname: Ye, Feng |
BookMark | eNp9UU1v1DAQtVARLaU_gFuOXLL1VxLnglRWLS0qggNI3KxZe7y4cuxiJ5X67_HuVohywAd75HnvzTy91-QopoiEvGV0JYQaz93kzWbFKWeroWN0EC_ICet72QrKfxz9VR-Ts1LuaD2S8nq_IsdC9lTwoTshn9bBR28gNJcPEBaYfYpNcg00n3GGLcZUx5T2AxS0zUUp8Ni4lJuvEZcpRV9hECtswji_IS8dhIJnT-8p-X51-W193d5--XizvrhtjZR8bu2md9xhZ4WzG2EMR7Rc9lIiMxQ6wZUcFY4jjoJx2_d1ZVXb3DEmR8eoOCU3B12b4E7fZz9BftQJvN5_pLzVkGdvAmrHu8EpaoRVQ7WsgHEAJZyhnWKsl1Xr_UHrftlMaE21kSE8E33eif6n3qYHraRiwyCqwLsngZx-LVhmPfliMASImJai6wIjHauFHZQdoCanUjK6P2MY1btI9T5SvYtUHyKtnOEfjvHzPqS6jQ__Yf4G5PinDg |
CitedBy_id | crossref_primary_10_3389_fcimb_2023_1112229 crossref_primary_10_1016_j_heliyon_2023_e23188 crossref_primary_10_3389_fcimb_2023_1135460 crossref_primary_10_3389_fcimb_2024_1439472 crossref_primary_10_3389_fcimb_2022_977591 crossref_primary_10_1007_s12223_024_01134_7 crossref_primary_10_1016_j_heliyon_2024_e31677 crossref_primary_10_1186_s12931_024_02991_z crossref_primary_10_12677_acm_2025_151155 crossref_primary_10_3389_fmed_2022_952636 crossref_primary_10_1128_spectrum_03812_22 crossref_primary_10_1007_s40291_024_00727_9 crossref_primary_10_3389_fmicb_2022_927842 crossref_primary_10_1007_s15010_023_02144_2 crossref_primary_10_1016_j_heliyon_2024_e36405 crossref_primary_10_2147_IDR_S374906 crossref_primary_10_2147_IDR_S387134 crossref_primary_10_3389_fcimb_2024_1397733 crossref_primary_10_3389_fcimb_2022_904485 crossref_primary_10_1186_s12890_022_02300_8 crossref_primary_10_2147_IDR_S394265 crossref_primary_10_2147_IDR_S359596 crossref_primary_10_3389_fmicb_2022_819467 crossref_primary_10_3389_fcimb_2022_851891 crossref_primary_10_1016_j_cca_2022_10_008 crossref_primary_10_3389_fmed_2022_812698 crossref_primary_10_3389_fmed_2023_1195629 |
Cites_doi | 10.3389/fmicb.2017.01069 10.1016/S0140-6736(15)60733-4 10.1111/crj.12674 10.1146/annurev-pathmechdis-012418-012751 10.1101/gr.171934.113 10.1152/ajplung.00476.2018 10.1186/s13059-016-0969-1 10.1007/s00134-019-05519-y 10.1111/crj.13369 10.1111/j.1469-0691.2012.03765.x 10.1093/cid/cix647 10.1007/s00134-019-05906-5 10.1093/cid/ciy723 10.1186/s40168-019-0678-6 10.1093/cid/ciy693 10.21037/jtd.2019.06.09 10.1097/MCP.0000000000000051 10.1093/bioinformatics/bty560 10.1007/s10096-021-04254-x 10.1093/bioinformatics/btp324 10.1128/mBio.01888-15 10.1038/s41582-020-0374-y 10.1093/cid/ciy802 10.1093/cid/cix881 10.1038/s41576-019-0113-7 10.1093/infdis/jiz151 10.1080/1040841X.2019.1681933 10.1038/nprot.2016.090 10.1016/j.jinf.2021.01.029 10.1093/cid/ciaa035 10.1101/gr.238170.118 10.1056/NEJMoa1803396 10.1016/S2213-2600(18)30345-X 10.1186/s13073-014-0114-2 10.1086/653033 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye. Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye. 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye |
Copyright_xml | – notice: Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye. – notice: Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye. 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fmicb.2021.751073 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-302X |
ExternalDocumentID | oai_doaj_org_article_f257f80c3d874608a12aa83fc0581164 PMC8481773 10_3389_fmicb_2021_751073 |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK ECGQY GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c442t-db6f2fe5d3fdb3cc2eed24644e1c0a5328498e99e9312d6620084642f1149f103 |
IEDL.DBID | M48 |
ISSN | 1664-302X |
IngestDate | Wed Aug 27 01:28:14 EDT 2025 Thu Aug 21 18:16:00 EDT 2025 Fri Jul 11 04:37:18 EDT 2025 Thu Apr 24 23:06:23 EDT 2025 Tue Jul 01 04:33:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-db6f2fe5d3fdb3cc2eed24644e1c0a5328498e99e9312d6620084642f1149f103 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Bernard Joseph Hudson, New South Wales Health Pathology, Australia; Nicolas Leveque, University of Poitiers, France This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology These authors have contributed equally to this work Edited by: David Andes, University of Wisconsin-Madison, United States |
OpenAccessLink | https://doaj.org/article/f257f80c3d874608a12aa83fc0581164 |
PMID | 34603275 |
PQID | 2579090083 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f257f80c3d874608a12aa83fc0581164 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8481773 proquest_miscellaneous_2579090083 crossref_primary_10_3389_fmicb_2021_751073 crossref_citationtrail_10_3389_fmicb_2021_751073 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-09-16 |
PublicationDateYYYYMMDD | 2021-09-16 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-16 day: 16 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in microbiology |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Kalantar (B18) 2019; 316 Dulanto Chiang (B10) 2020; 221 Prina (B25) 2015; 386 Letourneau (B19) 2014; 20 Shi (B28) 2019; 11 Chen (B6) 2018; 34 Chiu (B8) 2019; 20 (B32) 2020 Hogan (B17) 2020; 72 Avraham (B1) 2016; 11 Naccache (B23) 2014; 24 Wilson (B33) 2019; 380 Simner (B29) 2018; 66 Chen (B7) 2021; 15 Peng (B24) 2021; 82 Ramachandran (B26) 2020; 16 Miao (B21) 2018; 67 Ramirez (B27) 2017; 65 Forbes (B12) 2017; 8 Torres (B31) 2019; 45 Zinter (B36); 7 Azoulay (B3) 2020; 46 Di Pasquale (B9) 2019; 68 Sousa (B30) 2013; 19 Zinter (B35); 68 Fournier (B13) 2014; 6 Miller (B22) 2019; 29 Azoulay (B2) 2019; 7 Li (B20) 2009; 25 Han (B16) 2019; 45 Cao (B5) 2018; 12 Flygare (B11) 2016; 17 Zhang (B34) 2021; 40 Barriere (B4) 2010; 51 Gu (B15) 2019; 14 Goldberg (B14) 2015; 6 |
References_xml | – volume: 8 start-page: 1069 year: 2017 ident: B12 article-title: Metagenomics: the next culture-independent game changer. publication-title: Front. Microbiol. doi: 10.3389/fmicb.2017.01069 – volume: 386 start-page: 1097 year: 2015 ident: B25 article-title: Community-acquired pneumonia. publication-title: Lancet doi: 10.1016/S0140-6736(15)60733-4 – volume: 12 start-page: 1320 year: 2018 ident: B5 article-title: Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese thoracic society, chinese medical association. publication-title: Clin. Respir. J. doi: 10.1111/crj.12674 – volume: 14 start-page: 319 year: 2019 ident: B15 article-title: Clinical metagenomic next-generation sequencing for pathogen detection. publication-title: Annu. Rev. Pathol. doi: 10.1146/annurev-pathmechdis-012418-012751 – volume: 24 start-page: 1180 year: 2014 ident: B23 article-title: A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. publication-title: Genome Res. doi: 10.1101/gr.171934.113 – year: 2020 ident: B32 publication-title: The Top 10 Causes of Death. – volume: 316 start-page: L578 year: 2019 ident: B18 article-title: Metagenomic comparison of tracheal aspirate and mini-bronchial alveolar lavage for assessment of respiratory microbiota. publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. doi: 10.1152/ajplung.00476.2018 – volume: 17 start-page: 111 year: 2016 ident: B11 article-title: Taxonomer: an interactive metagenomics analysis portal for universal pathogen detection and host mRNA expression profiling. publication-title: Genome Biol. doi: 10.1186/s13059-016-0969-1 – volume: 45 start-page: 159 year: 2019 ident: B31 article-title: Challenges in severe community-acquired pneumonia: a point-of-view review. publication-title: Intens. Care Med. doi: 10.1007/s00134-019-05519-y – volume: 15 start-page: 815 year: 2021 ident: B7 article-title: Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: an observational study. publication-title: Clin. Respir. J. doi: 10.1111/crj.13369 – volume: 19 start-page: 187 year: 2013 ident: B30 article-title: Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome. publication-title: Clin. Microbiol. Infect. doi: 10.1111/j.1469-0691.2012.03765.x – volume: 65 start-page: 1806 year: 2017 ident: B27 article-title: Adults hospitalized with pneumonia in the united states: incidence, epidemiology, and mortality. publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cix647 – volume: 46 start-page: 298 year: 2020 ident: B3 article-title: Diagnosis of severe respiratory infections in immunocompromised patients. publication-title: Intensive Care Med. doi: 10.1007/s00134-019-05906-5 – volume: 68 start-page: 1482 year: 2019 ident: B9 article-title: Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciy723 – volume: 7 start-page: 62 ident: B36 article-title: Towards precision quantification of contamination in metagenomic sequencing experiments. publication-title: Microbiome doi: 10.1186/s40168-019-0678-6 – volume: 67 start-page: S231 year: 2018 ident: B21 article-title: Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciy693 – volume: 11 start-page: 2581 year: 2019 ident: B28 article-title: Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). publication-title: J. Thorac. Dis. doi: 10.21037/jtd.2019.06.09 – volume: 20 start-page: 272 year: 2014 ident: B19 article-title: Pneumonia in the immunocompromised host. publication-title: Curr. Opin. Pulm Med. doi: 10.1097/MCP.0000000000000051 – volume: 34 start-page: i884 year: 2018 ident: B6 article-title: fastp: an ultra-fast all-in-one FASTQ preprocessor. publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty560 – volume: 40 start-page: 1933 year: 2021 ident: B34 article-title: Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients. publication-title: Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-021-04254-x – volume: 25 start-page: 1754 year: 2009 ident: B20 article-title: Fast and accurate short read alignment with Burrows-Wheeler transform. publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – volume: 6 start-page: e01888 year: 2015 ident: B14 article-title: Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics. publication-title: mBio doi: 10.1128/mBio.01888-15 – volume: 16 start-page: 547 year: 2020 ident: B26 article-title: Metagenomics for neurological infections - expanding our imagination. publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-020-0374-y – volume: 68 start-page: 1847 ident: B35 article-title: Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children. publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciy802 – volume: 66 start-page: 778 year: 2018 ident: B29 article-title: Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cix881 – volume: 20 start-page: 341 year: 2019 ident: B8 article-title: Clinical metagenomics. publication-title: Nat. Rev. Genet. doi: 10.1038/s41576-019-0113-7 – volume: 221 start-page: S331 year: 2020 ident: B10 article-title: From the pipeline to the bedside: advances and challenges in clinical metagenomics. publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiz151 – volume: 45 start-page: 668 year: 2019 ident: B16 article-title: mNGS in clinical microbiology laboratories: on the road to maturity. publication-title: Crit. Rev. Microbiol. doi: 10.1080/1040841X.2019.1681933 – volume: 11 start-page: 1477 year: 2016 ident: B1 article-title: A highly multiplexed and sensitive RNA-seq protocol for simultaneous analysis of host and pathogen transcriptomes. publication-title: Nat. Protoc. doi: 10.1038/nprot.2016.090 – volume: 82 start-page: 22 year: 2021 ident: B24 article-title: Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. publication-title: J. Infect. doi: 10.1016/j.jinf.2021.01.029 – volume: 72 start-page: 239 year: 2020 ident: B17 article-title: Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study. publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa035 – volume: 29 start-page: 831 year: 2019 ident: B22 article-title: Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. publication-title: Genome Res. doi: 10.1101/gr.238170.118 – volume: 380 start-page: 2327 year: 2019 ident: B33 article-title: Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1803396 – volume: 7 start-page: 173 year: 2019 ident: B2 article-title: Acute respiratory failure in immunocompromised adults. publication-title: Lancet Respir Med. doi: 10.1016/S2213-2600(18)30345-X – volume: 6 start-page: 114 year: 2014 ident: B13 article-title: Clinical detection and characterization of bacterial pathogens in the genomics era. publication-title: Genome Med. doi: 10.1186/s13073-014-0114-2 – volume: 51 start-page: S4 year: 2010 ident: B4 article-title: Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective. publication-title: Clin. Infect. Dis. doi: 10.1086/653033 |
SSID | ssj0000402000 |
Score | 2.466588 |
Snippet | Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 751073 |
SubjectTerms | cytomegalovirus metagenomic next-generation sequence Microbiology pathogens pneumocystis jirovecii pneumonia |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La8MwDDZjMNhl7Mm6Fx7sNMjm-JHEx3W0lELHDiv0ZhzHZoWSjrU99N9PStLSXLbLrolFHEm29GH5EyEPLMXrlTKJkoQXkcyTEAFWSSIp84Ip5qyyeFF49JYMxnI4UZOdVl9YE1bTA9eKew7gUyFjThRZKhOW2Zhbm4ngmMpiyPVx94WYtwOmqj0YYRFrjjEBhWkw09TlgAd5_JSCH6aiFYgqvv5WktkukdyJOf1jctQki_SlnuQJ2fPlKTmo20euz8iwIfWc0d6Ws5vOA7V05JcW2VdhNouoC4GqoGAHu6aQotL30q_A-aYwbFv7ck7G_d7H6yBqeiNETkq-jPD2HA9eFSIUuXCOQ6zjEpIbHztmlYCoozOvtdci5gUYAonzAWsEwD86xExckP1yXvpLQnlehAzEhI6dBICSMZUHkOBpsNwp1SFsoyjjGuJw7F8xMwAgULem0q1B3Zpatx3yuBX5qlkzfhvcRe1vByLhdfUA3MA0bmD-coMOud_YzsACwVMPW_r5amFAUDONqWaHpC2jtr7YflNOPyuqbWw2kKbi6j-meE0O8a-x2CRObsj-8nvlbyGjWeZ3lfP-AFKA8gk priority: 102 providerName: Directory of Open Access Journals |
Title | Clinical Evaluation of a Metagenomics-Based Assay for Pneumonia Management |
URI | https://www.proquest.com/docview/2579090083 https://pubmed.ncbi.nlm.nih.gov/PMC8481773 https://doaj.org/article/f257f80c3d874608a12aa83fc0581164 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEC7WFcGL-MTxsbTgScjS704OIq7suiyMeHBgbk2n060DQ0bnAc6_tyrJDAYWwUsgSVceVd2p-tJdXwG85Y7SK7UtrJVNoWubC8QqttC6brjhMZhAicLTL_Z6pm_mZn4Ch_JWgwI3t0I7qic1Wy_Pf__af8AB_54QJ_pbtMAi1gj1pDh32MWcugN30TE5GqfTIdrvPsyElbqkFGEtzQfIeT_PeftVRp6qI_QfRaHjNZR_OaWrh_BgiCbZx978j-AktY_hXl9fcv8EbgbWzyW7PJJ6s1VmgU3TNhA9Kz7NprhAT9YwNFTYM4xh2dc27bB3LrDZcXHMU5hdXX77dF0MxROKqLXcFpReJ3MyjcpNrWKU6AylxugniciDUeiWqjJVVaqUkA1aipj1EYxkBEhVFlw9g9N21abnwGTd5BLFVCUiqlWX3NQZJaTLQUZjJsAPivJxYBanAhdLjwiDdOs73XrSre91O4F3R5GfPa3GvxpfkPaPDYkRuzuwWn_3wwDzGb89ueRRNaXTlpdByBBKlSM3pUBMOIE3B9t5HEE0LRLatNptPApWvKJYdAJuZNTRHcdn2sWPjoubqhE4p178z_u8hPu0R6tOhH0Fp9v1Lr3G0GZbn3W_BHD7eS7Ous77B0_Q9mY |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Evaluation+of+a+Metagenomics-Based+Assay+for+Pneumonia+Management&rft.jtitle=Frontiers+in+microbiology&rft.au=Zhan%2C+Yangqing&rft.au=Xu%2C+Teng&rft.au=He%2C+Fusheng&rft.au=Guan%2C+Wei-jie&rft.date=2021-09-16&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=12&rft_id=info:doi/10.3389%2Ffmicb.2021.751073&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fmicb_2021_751073 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon |